Granted Patent B2

US 9,339,498 · App. 14/644,602 · Granted May 17, 2016

Inventors: Lisa L. Wolfe (Fort Collins, CO); Michael W. Miller (Fort Collins, CO); William R. Lance (Fort Collins, CO); David K. Smith (Windsor, CO)

Assignee: Wildlife Laboratories, Inc.

A61K31/485A61K9/0019A61K31/4174A61K31/496

Abstract

Claims (6)

1. An injectable agent for sedating and immobilizing non-domesticated mammalian animals comprising a pharmaceutically effective combination of nalbuphine hydrochloride and medetomidine hydrochloride, wherein the combination is a liquid solution and the approximate relative weight ratio relationship of the pharmaceutically effective ingredients is 14-55 mg/ml of nalbuphine hydrochloride and 5-22 mg/ml of medetomidine hydrochloride.

2. An agent as defined in claim 1 , wherein the approximate relative weight ratio relationship of the pharmaceutically effective ingredients is 40 mg/ml of nalbuphine hydrochloride and 10 mg/ml of medetomidine hydrochloride.

3. An agent as defined in claim 1 , wherein the combination further includes azaperone tartrate.

4. An agent as defined in claim 3 , wherein the relative weight ratio relationship of the pharmaceutically effective ingredients is 14-55 mg/ml of nalbuphine hydrochloride, 5-22 mg/ml of azaperone tartrate and 5-22 mg/ml of medetomidine hydrochloride.

5. An agent as defined in claim 3 , wherein the approximate relative weight ratio relationship of the pharmaceutically effective ingredients is 40 mg/ml of nalbuphine hydrochloride, 10 mg/ml of medetomidine hydrochloride and 10 mg/ml of azaperone tartrate.

6. An agent as defined in claim 4 , wherein an effective amount of the liquid solution is no more than 3 milliliters.

Assignments (11)

Continuity (2)